Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCLL.L Regulatory News (CLL)

  • There is currently no data for CLL

Year end trading update

19 Jan 2009 07:00

RNS Number : 8037L
Cello Group plc
19 January 2009
 



19 January 2009

  

Cello Group plc

Year end trading update

 

Cello Group plc ("Cello" or the "Group", AIM: CLL), the leading independent market research and consulting group, today provides the following trading update for the year ended 31 December 2008

 

Since the announcement of the Group's interim results in early September, trading has tightened across certain sectors of Cello's broad domestic and international client base As a result, the Board anticipates that the Group's results for the full year will be at the lower end of market expectations.

There has been very strong cash conversion in the second half of 2008, as a result of which the Board expects to report year end net debt of less than £10.5m, significantly below consensus expectations.

The Group has agreed enlarged banking facilities with the revolving credit facility now increased from £18.0m to £20.0m for 2009, amortising to £17.0m for 2010. The overdraft facility of £2.0m has also been renewed and is now a multi-currency arrangement. The extra interest cost associated with these changes is expected to be broadly offset by lower overall interest rates.

The Group has re-estimated its total anticipated earn out obligations. These are now expected to be £15.2m compared with a previous estimate of £19.2m, with a minimum loan note component of £6.3m and the balance of £8.9m payable in shares. £7.8m of this total is anticipated to be settled in May 2009 with £3.2m payable in loan notes and £4.6m payable in shares. The balance of the total earn out commitment is payable between 2010 and 2013, with a loan note payment of £0.6m expected to be paid in 2010. The Group is entitled to pay an increased proportion of these total obligations in loan notes.

As well as the strong operating cash position and the reduced earn out provisions, the Group has continued to prudently reduce its cost base. In total over £2.0m of staff costs, on an annualised basis, have been removed during 2008.

Allan Rich, whose appointment as Acting Non-Executive Chairman was announced on September 2008has been confirmed as Non-Executive Chairman. Allan brings with him a wealth of experience of managing successfully through economic downturns.

 

The Group remains realistically cautious about the current outlook. While it is too early to give detailed guidance, numerous clients have indicated their intention to maintain their expenditure levels and the Group is seeing refreshed levels of spend from several of its public sector clients. In addition, all of Cello's investment start-up businesses are now trading profitably. All these factors, including the Group's strong financial position, should hold the Group in good stead in the current economic environment.

 

Cello expects to announce its preliminary results for the year ended 31 December 2008 on Tuesday 17 March 2009.

 

Enquiries

 

Cello Group 

 

Mark ScottChief Executive

020 7812 8460

Mark Bentley, Finance Director

 

Singer Capital Markets

 

Nicholas How

020 3205 7620

 

 

College Hill

 

Adrian Duffield/Rozi Morris

020 7457 2020

 

 

Notes to Editors (www.cellogroup.co.uk)

 

Cello is a market research and consulting group that listed on AIM in November 2004.

 

The Group's strategy is to create value for shareholders by building a world class market research business and a leading direct response business.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCGUUACGUPBGAQ
Date   Source Headline
16th May 20114:35 pmRNSHolding in Company
16th May 20119:05 amRNSHolding in Company
11th May 20117:00 amRNSAdditional listing / TVR
28th Apr 201111:29 amRNSNotice of AGM and Annual Report and Accounts
11th Apr 20117:00 amRNSAcquisition
1st Apr 201112:47 pmRNSTotal Voting Rights
25th Mar 201112:25 pmRNSHolding(s) in Company
22nd Mar 20114:45 pmRNSHolding(s) in Company
22nd Mar 20114:20 pmRNSCompletion of Acquisition and Placing / TVR
15th Mar 20117:00 amRNSAcquisition and Placing
15th Mar 20117:00 amRNSFinal Results
24th Jan 201111:22 amRNSNotice of Results
19th Jan 20117:00 amRNSTrading update
27th Oct 20105:50 pmRNSHolding(s) in Company
14th Sep 20107:00 amRNSInterim Results
3rd Sep 20104:15 pmRNSHolding(s) in Company
1st Sep 20105:10 pmRNSHolding in Company
29th Jul 201012:24 pmRNSNotice of Results
22nd Jul 20107:00 amRNSBoard Appointment
22nd Jul 20107:00 amRNSPre-close trading update
19th Jul 201011:33 amRNSBoard Change
17th Jun 201010:00 amRNSHolding in Company
9th Jun 20107:00 amRNSDirector/PDMR Shareholding
7th Jun 201011:45 amRNSHolding(s) in Company
4th Jun 20101:10 pmRNSShare Option Grants
17th May 20101:15 pmRNSResult of AGM
17th May 20107:00 amRNSAGM Statement
30th Apr 20107:00 amRNSAdditional Listing / TVR
15th Apr 201012:44 pmRNSAnnual report & accounts & AGM notice
16th Mar 20107:00 amRNSFull Year Results
16th Feb 201011:41 amRNSNotice of Results
20th Jan 201010:30 amRNSHolding(s) in Company
19th Jan 20107:00 amRNSTrading Update
15th Sep 20097:00 amRNSInterim Results
10th Aug 200912:30 pmRNSChange in director's details
7th Aug 20099:45 amRNSChange of Adviser
5th Aug 20099:00 amRNSNotice of Results
3rd Jul 20097:00 amRNSTrading Statement
19th May 200912:46 pmRNSAGM Statement
15th May 20097:00 amRNSHolding(s) in Company
8th May 20092:55 pmRNSDigital capability widened
23rd Apr 20099:52 amRNSAnnual Report and Accounts
23rd Apr 20097:00 amRNSAdditional listing / TVR
16th Apr 20097:00 amRNSAdditional Listing/TVR
6th Apr 20097:00 amRNSDirector/PDMR Shareholding
2nd Apr 20095:28 pmRNSTransaction in Own Shares
1st Apr 20094:33 pmRNSTransaction in Own Shares
1st Apr 20094:33 pmRNSTransaction in Own Shares
27th Mar 20094:57 pmRNSTransaction in Own Shares
26th Mar 20094:18 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.